July 2025
1. NAYYER MA, Rasool H, Murtaza H, Safdar MR, et al
   Tegoprazan vs. proton pump inhibitors for erosive esophagitis: a superior alternative or just another option? A systematic review and meta-analysis of randomized controlled trials.
   Eur J Gastroenterol Hepatol. 2025 Jul 14. doi: 10.1097/MEG.0000000000003030.
   

   >> Share

   
   June 2025
2. CALABRESE F, Pasta A, Bodini G, Furnari M, et al
   Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia.
   Eur J Gastroenterol Hepatol. 2025 Jun 4. doi: 10.1097/MEG.0000000000002989.
   

   >> Share

   
   April 2025
3. EL-AZAB G, Zakareya T, Abdel Aleem M, Edrees A, et al
   Inappropriate use of proton pump inhibitors in patients with liver cirrhosis: a cross-sectional study.
   Eur J Gastroenterol Hepatol. 2025 Apr 29. doi: 10.1097/MEG.0000000000002985.
   

   >> Share

   
   March 2025
4. WANG D, An TY, Hu QM, Hua YQ, et al
   Helicobacter pylori promotes YTHDF2-mediated SRA1 m6A modification and promotes the occurrence and development of gastric cancer.
   Eur J Gastroenterol Hepatol. 2025 Mar 21. doi: 10.1097/MEG.0000000000002972.
   

   >> Share

   
   February 2025
5. MAIMARIS S, Mangili L, Minerba P, Massetti G, et al
   Prevalence of gastroesophageal reflux disease in adult coeliac disease at diagnosis and during follow-up: a 20-year retrospective study.
   Eur J Gastroenterol Hepatol. 2025 Feb 21. doi: 10.1097/MEG.0000000000002953.
   

   >> Share

   
   January 2025
6. ZAIDI SMM, Alvi MH, Irfan Q, Abbasi L, et al
   The use of pre-endoscopic metoclopramide in patients with upper gastrointestinal bleeding: a systematic review and meta-analysis.
   Eur J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1097/MEG.0000000000002927.
   

   >> Share

   
   October 2024
7. KOZAI L, Tan A, Nebrejas K, Nishimura Y, et al
   Comparative diagnostic utility of Rockall and Glasgow-Blatchford scores in non-variceal upper gastrointestinal bleeding: a systematic review and meta-analysis.
   Eur J Gastroenterol Hepatol. 2024 Oct 11. doi: 10.1097/MEG.0000000000002867.
   

   >> Share

   
   September 2024
8. ZHUO M, Fang M, Yin Y, Wang J, et al
   Investigating the prevalence burden of peptic ulcer disease in older adults aged 70+ from 1990 to 2019: an analysis of Global Disease Burden Studies.
   Eur J Gastroenterol Hepatol. 2024 Sep 12. doi: 10.1097/MEG.0000000000002847.
   

   >> Share

   
   July 2024
9. LAM SK, Lau GKK
   Proton pump inhibitors are not associated with fundic gland polyps - a systematic review that takes into consideration all known confounders.
   Eur J Gastroenterol Hepatol. 2024;36:831-844.
   

   >> Share

   
   May 2024
10. SMITH SM, Boyle B, Buckley M, Costigan C, et al
    The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2024 May 30. doi: 10.1097/MEG.0000000000002796.
    

    >> Share

    
    April 2024
11. LIU J, Zhang T, Liu X, Wang Q, et al
    Causal effect between gut microbiota and gastroesophageal reflux disease: a bidirectional two-sample Mendelian randomization study.
    Eur J Gastroenterol Hepatol. 2024 Apr 15. doi: 10.1097/MEG.0000000000002774.
    

    >> Share

    
    March 2024
12. QIAO Z, Wang E, Bao B, Tan X, et al
    Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002765.
    

    >> Share

    
    
13. LIU Z, Sun D, Kou L, Jia L, et al
    Vonoprazan-amoxicillin dual therapy with different amoxicillin dosages for treatment-naive patients of Helicobacter pylori infection in China: a prospective, randomized controlled study.
    Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002760.
    

    >> Share

    
    
14. SARIKAYA B, Cetinkaya RA, Ozyigitoglu D, Isik SA, et al
    High antibiotic resistance rates in Helicobacter pylori strains in Turkey over 20 years: implications for gastric disease treatment.
    Eur J Gastroenterol Hepatol. 2024 Mar 11. doi: 10.1097/MEG.0000000000002733.
    

    >> Share

    
    September 2023
15. GINGOLD-BELFER R, Issa N, Boltin D, Beloosesky Y, et al
    Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use.
    Eur J Gastroenterol Hepatol. 2023;35:968-973.
    

    >> Share

    
    August 2023
16. KROUPA R, Pavlik T, Konecny S, Packova B, et al
    The association between duration of and indications for proton pump inhibitor use and risk of gastric polyps.
    Eur J Gastroenterol Hepatol. 2023;35:829-835.
    

    >> Share

    
    June 2023
17. OKAMOTO T, Okamoto S, Yamamoto K, Takasu A, et al
    Bulbar and post-bulbar duodenal ulcers: characteristics based on location.
    Eur J Gastroenterol Hepatol. 2023 Jun 22. doi: 10.1097/MEG.0000000000002585.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share